TSC2 alterations in anaplastic ependymoma progression to ependymosarcoma

Area of Science:

• Neuro-oncology
• Cancer Genetics

Background:

• Ependymosarcomas are rare biphasic tumors with poorly understood biology.
• Anaplastic ependymoma (WHO grade III) is an aggressive subtype.

Observation:

• A case study of a 38-year-old male with anaplastic ependymoma.
• Tumor progression to ependymosarcoma occurred within two years despite aggressive treatment including surgery, chemoradiotherapy, and immunotherapy.

Findings:

• Next-generation sequencing identified genetic variants in tumor suppressor genes RB1, TP53, and TSC2.
• An additional TSC2 variant was noted in the ependymosarcoma, suggesting a role in tumor progression.

Implications:

• These findings offer insights into the genetic underpinnings of ependymosarcoma development.
• Understanding these genetic alterations may guide future therapeutic strategies for rare brain tumors.